Cerebral infarction complicating intravenous immunoglobulin therapy in a patient with Miller Fisher syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10811710.
- Also identified by PMC identifier 1736949.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intravenous immunoglobulin (IVIg) therapy is being increasingly used in a wide range of neurological conditions. However, treatment is expensive and side effects may be severe. A patient with Miller Fisher syndrome who developed cortical blindness as a consequence of occipital infarction precipitated by IVIg is reported on.
Medical subject headings
- Blindness, Cortical
- Cerebral Infarction
- Immunization, Passive
- Miller Fisher Syndrome
- Occipital Lobe